Brannin McBee - 17 Feb 2026 Form 4 Insider Report for CoreWeave, Inc. (CRWV)

Role
Chief Development Officer
Signature
/s/ Nisha Antony, as Attorney-in-Fact
Issuer symbol
CRWV
Transactions as of
17 Feb 2026
Net transactions value
-$3,055,910
Form type
4
Filing time
19 Feb 2026, 20:16:09 UTC
Previous filing
12 Feb 2026
Next filing
11 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
McBee Brannin Chief Development Officer C/O COREWEAVE, INC., 290 WEST MT. PLEASANT AVENUE, SUITE 4100, LIVINGSTON /s/ Nisha Antony, as Attorney-in-Fact 19 Feb 2026 0002058103

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRWV Class A Common Stock Conversion of derivative security +25,000 25,000 17 Feb 2026 Canis Major 2025 GRAT F1, F2
transaction CRWV Class A Common Stock Sale $171,858 -1,913 -7.7% $89.84 23,087 17 Feb 2026 Canis Major 2025 GRAT F2, F3, F4
transaction CRWV Class A Common Stock Sale $718,941 -7,931 -34% $90.65 15,156 17 Feb 2026 Canis Major 2025 GRAT F2, F3, F5
transaction CRWV Class A Common Stock Sale $587,608 -6,407 -42% $91.71 8,749 17 Feb 2026 Canis Major 2025 GRAT F2, F3, F6
transaction CRWV Class A Common Stock Sale $543,270 -5,860 -67% $92.71 2,889 17 Feb 2026 Canis Major 2025 GRAT F2, F3, F7
transaction CRWV Class A Common Stock Sale $186,435 -1,990 -69% $93.69 899 17 Feb 2026 Canis Major 2025 GRAT F2, F3, F8
transaction CRWV Class A Common Stock Sale $80,696 -853 -95% $94.60 46 17 Feb 2026 Canis Major 2025 GRAT F2, F3, F9
transaction CRWV Class A Common Stock Sale $4,387 -46 -100% $95.38 0 17 Feb 2026 Canis Major 2025 GRAT F2, F3
transaction CRWV Class A Common Stock Conversion of derivative security +8,315 8,315 17 Feb 2026 Canis Minor 2025 GRAT F1, F10
transaction CRWV Class A Common Stock Sale $57,136 -636 -7.6% $89.84 7,679 17 Feb 2026 Canis Minor 2025 GRAT F3, F4, F10
transaction CRWV Class A Common Stock Sale $239,133 -2,638 -34% $90.65 5,041 17 Feb 2026 Canis Minor 2025 GRAT F3, F5, F10
transaction CRWV Class A Common Stock Sale $195,441 -2,131 -42% $91.71 2,910 17 Feb 2026 Canis Minor 2025 GRAT F3, F6, F10
transaction CRWV Class A Common Stock Sale $180,781 -1,950 -67% $92.71 960 17 Feb 2026 Canis Minor 2025 GRAT F3, F7, F10
transaction CRWV Class A Common Stock Sale $61,927 -661 -69% $93.69 299 17 Feb 2026 Canis Minor 2025 GRAT F3, F8, F10
transaction CRWV Class A Common Stock Sale $26,867 -284 -95% $94.60 15 17 Feb 2026 Canis Minor 2025 GRAT F3, F9, F10
transaction CRWV Class A Common Stock Sale $1,431 -15 -100% $95.38 0 17 Feb 2026 Canis Minor 2025 GRAT F3, F10

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRWV Class B Common Stock Conversion of derivative security -25,000 -0.44% 5,700,000 17 Feb 2026 Class A Common Stock 25,000 Canis Major 2025 GRAT F1, F2
transaction CRWV Class B Common Stock Conversion of derivative security -8,315 -0.92% 900,000 17 Feb 2026 Class A Common Stock 8,315 Canis Minor 2025 GRAT F1, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.
F2 The reported securities are directly held by the Canis Major 2025 GRAT, of which the reporting person is the sole trustee and beneficiary.
F3 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2025.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.19 to $90.18, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.19 to $91.18, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.19 to $92.18, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.19 to $93.18, inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.19 to $94.16, inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.19 to $95.07, inclusive.
F10 The reported securities are directly held by the Canis Minor 2025 GRAT, of which the reporting person's spouse is the sole beneficiary and trustee.

Remarks:

This Form 4 is Part 3 of 3 for this reporting person. Transactions by the reporting person are continued on this Part 3.